Despite the challenges, including what CSL CEO Paul McKenzie has described as a fragmented U.S. healthcare system, the blood product specialist remains hopeful that Hemgenix is here to stay. “I hope ...

Despite significant advancements in spinal muscular atrophy (SMA) management, unmet needs persist, especially for patients ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

Belief BioMed (BBM) and Takeda China have announced China’s National Medical Products Administration's (NMPA) approval for ...

Proponents of methods including blood transfusions and gene therapy argue that they can extend longevity. Is it just a delusion?

Daiichi Sankyo Company, Limited leads in ADC tech with Enhertu, strong partnerships, revenue growth, and global market leadership. Click to know more on why DSNKY is a Buy.

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...